Cite
APA Citation
Abd-ellatef, G. E. F., Gazzano, E., El-Desoky, A. H., Hamed, A. R., Kopecka, J., Belisario, D. C., Costamagna, C., Marie, M. A. S., Fahmy, S. R., Abdel-Hamid, A. Z., & Riganti, C. (2023). corrigendum to 'Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein' [Pharmacol. Res. 175 (2022) 105975]. Pharmacological research, 189, . http://access.bl.uk/ark:/81055/vdc_100180187515.0x000024